Our Services
Our Brands
Upcoming Event: REPROCELL USA to attend the Digestive Disease Week (DDW) Conference
18-21 May 2019 / San Diego, California
Come say hello to REPROCELL’s Chris J. Hissom and find out about our services in this space.
Upcoming Event: REPROCELL Europe to attend the UK Life Science Trade Mission to Switzerland
14-15 May 2019 / Basel and Geneva, Switzerland
REPROCELL Europe Ltd will accompany the UK’s Department for International Trade and Scottish Development International Life Science Trade Mission to Switzerland.
Press Release: REPROCELL Launches cGMP suite in Kawasaki to Accelerate Development of iPSC-derived Glial Progenitors for treatment of CNS disorders
13 May 2019 / Kawasaki City, Japan
Establishment of cGMP cell processing suite at Life Innovation Center (LIC) in Tonomachi area in Kawasaki City for production of iPS Cell-derived Glial Progenitors (iGRP) for treatment of CNS disorders.
Upcoming Event: Swiss Biotech Day 2019
7 May 2019 / Congress Centre, Basel, Switzerland
REPROCELL’s Chirag Tawde will be there as a delegate, and will also join the partnering forum to discuss collaboration opportunities with REPROCELL.
Upcoming Event: Webinars: CRISPR/Cas9 using SNIPER Technology — Managing Challenging Cases
25 & 30 April 2019
Insights about an approach to shortening the timeline for gene editing projects by streamlining the most time-consuming step of CRISPR/Cas9 experiments: screening clones.
Announcement: Market Research Updates has released a report about New Developments with Operational Updates in Cryogenic Biobanking Services Market with top leading players
29 April 2019
The report covers and analyzes the Cryogenic Biobanking Services market and its major vendors, including REPROCELL’s brands in this space, the companies formerly known as BioServe and Stemgent.
Tissue Spotlight: Lung
29 April 2019
REPROCELL is leading the way in the provision of biologically relevant custom drug-discovery assays to aid researchers in lung diseases.
Stem Cells for Autism
3 April 2019
In this post, we highlight recent advancements in stem cells as treatment and study of autism to commemorate World Autism Awareness Day (2 April 2019).
Improving patient outcomes through collaboration
28 March 2019
As part of our collaboration with the Medicines Discovery Catapult (MDC), REPROCELL have pledged to provide custom drug discovery assays using live human tissues.
Spotlight: StemRNA Neuro iPSCs – Human Brain Neurons for Functional Assays
20 March 2019
Human induced pluripotent stem cell (iPSC) derived neural models to study brain disease provide an unlimited resource for disease modelling as well as being a tool for drug screening for effective therapies.
3D epithelial barrier assays in vitro: How to get the best balance between practicability and physiological relevance
13 March 2019
Bio-engineered 3D tissue models using Alvetex Scaffold restore the Z-dimension which is missing in flat-surface cell culture, allowing for the building of mucosal and sub-mucosal compartments in a single model.
Using human iPSCs as an in vitro model for regenerative medicine, drug screening and disease modelling
22 February 2019
The conventional drug discovery pathway is a very inefficient process. REPROCELL provides services for generating iPSCs from various tissue sources using our state-of-the-art StemRNA 3rd Gen Reprogramming technology.
Our Popular Products
